Results

Total Results: 1,601 records

Showing results for "chipra".

841. High-Risk Deliveries at Facilities with 24/7 In-House Blood Banking/Transfusion Services - Tables 2-5 (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0122-tables2-5.pdf
     June 02, 2025 - High-Risk Deliveries at Facilities with 24/7 In-House Blood Banking/Transfusion Services - Tables 2-5 TABLE 2 High-risk referral center Not a high-risk referral center P-value Facility Type Annual Delivery volume* Community hospital 61 (58.7%) 207 (91.6%) <0.001 Anesthesia residency 42 …

842. High-Risk Deliveries at Facilities with 24/7 In-House Blood Banking/Transfusion Services - Tables 7-8 (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0122-table7-8.pdf
     June 02, 2025 - High-Risk Deliveries at Facilities with 24/7 In-House Blood Banking/Transfusion Services - Tables 7-8 Quantile Percent in Pove TABLE 7 rty Maximum 49.9% 99 37.5% 95 28.9% 90 25.7% 75 20.7% 50 16.5% 25 12.5% 10 10.0% 5 8.6% 1 6.1% Minimum 2.9% TABLE 8 HROB Summary (Combined U…

843. Global Assessment of Pediatric Patient Safety (GAPPS) Trigger Tool (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-143-manual-operations-notice.pdf
     June 02, 2025 - Global Assessment of Pediatric Patient Safety (GAPPS) Trigger Tool Due to the length and complexity of the technical specifications for this measure, we are unable to post the file to our Web site. To request the technical specifications for this measure, please send an email to the AHRQ Pediatric Quality Measures …

844. Table 6 - HROB Summary (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0121-table-6.pdf
     June 02, 2025 - Table 6 - HROB Summary TABLE 6 HROB Summary (Combined Unduplicated) New York State Medicaid, 2010 Urbanicity UIC N OB Proxy1 Transfusion Proxy2 NICU >=33 URBAN Large Metropolitan 1 48,562 27.10% 14.62% 37.98% Small Metropolitan 2 7229 15.95% 10.26% 21.69% RURAL Adjacent to L…

845. High-Risk Deliveries at Facilities with 24/7 In-House Blood Banking/Transfusion Services - Tables 9-10 (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0122-tables9-10.pdf
     June 02, 2025 - High-Risk Deliveries at Facilities with 24/7 In-House Blood Banking/Transfusion Services - Tables 9-10 TABLE 9 UIC_2013 UIC_2013 Frequency Percent 1 432 13.74 2 735 23.39 3 130 4.14 4 149 4.74 5 242 7.70 6 344 10.94 7 162 5.15 8 269 8.56 9 184 …

846. Availability of Multidisciplinary Outpatient Care for Women with High-Risk Pregnancies: Tables 3-8 (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-0134-tables_3-8.pdf
     June 02, 2025 - Availability of Multidisciplinary Outpatient Care for Women with High-Risk Pregnancies: Tables 3-8 Table 3 Availability of multidisciplinary care for high risk pregnant women, defined as outpatient visits with at least 3 different types of providers during pregnancy. Urbanicity UIC N <3 visit ≥ 3 Visits …

847. Part 1: An Introduction to Care Management Entities (CMEs) | Agency for Healthcare Research and Quality
     www.ahrq.gov/policymakers/chipra/demoeval/what-we-learned/implementation-guides/implementation-guide2/implguide2pt1.html
     September 01, 2014 - Conclusion Endnotes Appendix A: Brief History of CMEs Appendix B: Key CME Design Features in CHIPRA

848. After The Demonstration: What States Sustained After the End of Federal Grants to Improve Children’s Health Care Quality (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/after-demonstration.pdf
     June 02, 2025 - 5vjffngd0)0ffn TjqwsapdffnQams,ffnECchipra … /demoeval/%20index.html http://www.ahrq.gov/policymakers/chipra/demoeval/%20index.html http://www.implementationscience.com

849. THE MEDICAL HOME INDEX: (doc file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/mhi-rsf.docx
     June 02, 2025 - MEDICAL HOME INDEX: Medical Home Index-Revised Short Form (MHI-RSF) for the National Evaluation of the CHIPRA

850. Associations Between Practice-Reported Medical Homeness and Health Care Utilization Among Publicly Insured Children (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/Christensen-presentation.pdf
     June 16, 2015 - model pediatric E HR format (C ategory D) • Other innovative approac hes (C ategory E ) CHIPRA … Medical Homeness & Non-Urgent ED Visits Conclusions Implications For More Information Extra Slides CHIPRA

851. Building partnerships to improve quality of children’s health care | Agency for Healthcare Research and Quality
     www.ahrq.gov/policymakers/chipra/demoeval/what-we-learned/finalsummary/finalsummary6.html
     September 01, 2015 - Key Lessons from the National Evaluation of the CHIPRA Quality Demonstration Grant Program Building … Previous Page Next Page Table of Contents Key Lessons from the National Evaluation of the CHIPRA

852. Background Report for the Request for Public Comment on Initial, Recommended Core Set of Children's Healthcare Quality Measures for Voluntary Use by Medicaid and CHIP Programs | Agency for Healthcare Research and Quality
     www.ahrq.gov/policymakers/chipra/overview/background/next-steps3.html
     December 01, 2009 - Return to Contents Family Experiences of Care The CHIPRA legislation explicitly asked for core … Return to Contents Availability of Services CHIPRA directed the Secretary to include measures of

853. Maternal and Child Health Care | Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/nhqrdr/chartbooks/healthyliving/mch-measures.html
     June 01, 2018 - health outcomes. 1-3 Resources through the Children’s Health Insurance Program Reauthorization Act (CHIPRA

854. Section 7-A, Tables 10, 11, and 12 (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-131-section-7-a-table-10-11-12.pdf
     January 01, 2008 - Section 7-A, Tables 10, 11, and 12 Table 10 – Analysis of Disparities in Readmission Risk Based on Race/Ethnicity 2005-2009 AHRQ Revisit data for New Yo…

855. Q-METRIC Sickle Cell Disease Measure 1, Section 8, Tables 7, 8, and 9 (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-132-scd-section-8-table-7-8-9.pdf
     October 01, 2013 - Q-METRIC Sickle Cell Disease Measure 1, Section 8, Tables 7, 8, and 9   Q-METRIC Sickle Cell Disease Measure 1: Timeliness of Confirmatory Testing for Sickle Cell Disease Graphics for Section VIII Feasibility VIII.A. Data Availability TABLE 7: Summary o…

856. Tables 8-11 (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-195-tables%208-11.pdf
     June 02, 2025 - Tables 8-11 Table 8. Mean (SD) Proportion of Racial Groups within Sampled ZIP Codes of Residence‡ Sampled Group Description American Indian or Alaska Native Mean(SD)‡ Asian Mean(SD)‡ Black or African American Mean(SD)‡ Native Hawaiian or Other Pacific Islander Mean(SD)‡ White Mean(SD)‡ …

857. Tables 1-7 (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-195-tables%201-7.pdf
     June 02, 2025 - Tables 1-7 Table 1. Contingency Table for Presence of Chart Review Exclusions Senior Abstractor Identified Chart-Based Exclusion Present Absent Total Abstractor Identified Chart-Based Exclusion Present 67 2 69 Absent 0 372 372 Total 67 374 441 Table 2. Contingency Table for Presence of S…

858. Figures 1-3 (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-195-figures-1-3.pdf
     June 30, 2015 - Figures 1-3 Figure 1. Path Between the Measure Focus and Health Outcome Child Suffers Post-Traumatic Headache and Seeks ED Care •Without signs or symptoms of intracranial injury •Without history of a condition that would warrant imaging CT Scan or MRI Overuse •Imaging obtained without lik…

859. Section 3-A, Tables (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-200-section-3-a-tables.pdf
     June 02, 2025 - Section 3-A, Tables Outcome Transfused Not transfused P value Patients 131 109 Average entry Hb 6.9 g/dL 8.1 g/dL < 0.001 Hospital mortality 8 (6.1%) 1 (0.9%) 0.043 Average oxygen days 8.0 ± 10.4 days 4.0 ± 6.6 days < 0.001 Mechanical ventilator days 5.6 ± 9.1 days 2.4 ± 4.1 days 0.002 …

860. Background Report for the Request for Public Comment on Initial, Recommended Core Set of Children's Healthcare Quality Measures for Voluntary Use by Medicaid and CHIP Programs | Agency for Healthcare Research and Quality
     www.ahrq.gov/policymakers/chipra/overview/background/appendix-a6.html
     December 01, 2009 - Background Report for the Request for Public Comment on Initial, Recommended Core Set of Children's Healthcare Quality Measures for Voluntary Use by Medicaid and CHIP Programs Background Report on request for public comment on initial, recommended core set of Children's Healthcare Quality Measures for voluntary…